UofL Health’s frontline workers the first in Kentucky to receive Pfizer’s COVID-19 vaccine
UofL Health welcomed Governor Andy Beshear 14 Dec. to mark a historic moment in the fight against the COVID-19 pandemic. The first vaccines shipped...
UofL innovator known for drug discovery inducted into National Academy of Inventors Trent is the seventh from UofL to achieve the recognition
John Trent, a University of Louisville researcher and innovator known for harnessing the power of thousands of computers to discover drugs that could fight...
UofL researcher uses fruit for less toxic drug delivery Suite of technologies now has commercial partner to bring them to market
UofL researchers have found a less toxic way to deliver medicines by using the natural lipids in plants, particularly grapefruit and ginger.
The resulting intellectual...
UofL doctor is a participant in Pfizer’s COVID-19 vaccine trial
Pharmaceutical company Pfizer and its collaborator, BioNTech, announced today that early results in a Phase 3 clinical trial show their COVID-19 vaccine candidate is...
Civil Engineering student part of National Women in Engineering “Dream Team” panel
Civil Engineering Junior Sophie Lipomanis is kind of a rock star in civil engineering. Named for a second year in a row as a...
UofL research teams chosen for prestigious national innovation program Program provides training and $50,000 in funding to translate the ideas from the lab into new, technology-backed startups
Two University of Louisville research teams have been chosen to participate in a prestigious, nationally competitive innovation program through the National Science Foundation.聽
The NSF鈥檚...
UofL鈥檚 contribution to Louisville鈥檚 鈥榚quitable economic recovery鈥 featured in Forbes
The City of Louisville was recently in the spotlight for a Forbes article about 鈥渆quitable economic recovery.鈥 What that means exactly is the ability...
UofL cell therapy startup acquired by publicly-traded biotech firm UofL to lead planned clinical trial for COVID-19-related acute respiratory distress
A University of Louisville-born startup using innovative personalized cell therapies to help patients with pancreatitis and other conditions has been acquired by publicly traded...
UofL-born company secures an additional $115 million to advance cell therapy Funding comes on the heels of $100 million raised last year
A company born at the University of Louisville has raised an additional $115 million to further develop a therapy that could improve the lives...
UofL to advance carbon dioxide reduction research with new DOE grant
Researchers at the University of Louisville Conn Center for Renewable Energy Research and Department of Chemistry are working to convert the greenhouse gas carbon...